{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-004632","form_type":"8-K","ticker":"UG","cik":"0000101295","company_name":"UNITED GUARDIAN INC","filed_at":"2024-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.875342+00:00","generated_at":"2026-05-31T10:18:42.761113+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"United-Guardian Q2 2024 Sales Rise 28% to $3.39M, Net Income More Than Doubles to $956K","bullets":["Net income for Q2 2024 was $956,225 ($0.21 per share) vs. $461,094 ($0.10 per share) in Q2 2023.","Cosmetic ingredient sales surged 84% in Q2 and 115% for the first six months of 2024.","Medical lubricant sales increased 15% in Q2 and 9% for the first half of 2024.","Pharmaceutical sales rose 3% in Q2 but fell 13% for the six months due to Renacidin contract manufacturer shutdown; production resumed late March.","Six-month sales reached $6.65 million and net income was $1.88 million, up from $5.22 million and $1.22 million a year earlier."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-004632","json":"https://secwatch.observer/filing/0001171843-24-004632.json","markdown":"https://secwatch.observer/filing/0001171843-24-004632.md","text":"https://secwatch.observer/filing/0001171843-24-004632.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/101295/000117184324004632/0001171843-24-004632-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/101295/000117184324004632/f8k_080824.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:18:42.761113+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}